Day 1
Basic Vaccinology / Principles and Practice of Vaccinology | Talk 1 | Special Lecture 1 | TBA |
| Talk 2 | Vaccines: Fundamental Principles, Development Pathways, Manufacturing, and Next-Generation Platforms | TBA |
| Talk 3 | Impact of vaccination, forecasting and projections using mathematical modeling | TBA |
| Talk 4 | Vaccine effectiveness in real-world populations | TBA |
| Talk 5 | Immunization strategies and lessons learned, Role of vaccines in disease eradication initiatives | TBA |
| Talk 6 | Immune Mechanisms and Correlates of Protection: Roles of Antibodies, B Cells, T Cells, and Mucosal Immunity | TBA |
| Talk 7 | Ensuring vaccine quality and safety: concepts of Chemistry, Manufacturing, and Controls (CMC) | TBA |
| Working Group Session | Phases of clinical trials, Statistical methodologies and data interpretation | TBA |
| Panel | Cold Chain Management, Inventory and Stock Management: Principles of cold chain logistics, Inventory and Stock Management | TBA |
| Panelist | TBA | TBA |
| Panelist | TBA | TBA |
| Panelist | TBA | TBA |
| Panelist | TBA | TBA |
Day 2
Vaccine Policy, Management, and Equity | Talk 1 | Special Lecture 2 | TBA |
| Talk 2 | Mechanisms by which vaccines may cause adverse effects | TBA |
| Talk 3 | Economic evaluations in vaccine policy decisions | TBA |
| Talk 4 | Global and Regional Vaccine Markets: Strategies, Challenges, and the Road to Self-Reliance | TBA |
| Talk 5 | Leadership, change management, and strategic planning for immunization managers | TBA |
| Talk 6 | Developing Vaccines Rapidly During Pandemics and Emerging Pathogens Outbreaks | TBA |
| Working Group Session | Understanding and addressing Vaccine Hesitancy: Identifying and addressing Vaccine Hesitancy and Demand Generation | TBA |
| Panel | Strategies to Reach Underserved Populations: Identifying and tailoring interventions to reach zero-dose and under-vaccinated communities | TBA |
| Panelist | TBA | TBA |
| Panelist | TBA | TBA |
| Panelist | TBA | TBA |
Day 3
Advances in Disease-Specific Vaccines | Talk 1 | Pneumococcal Vaccines: Impact and evolution of conjugate vaccines | TBA |
| Talk 2 | HPV Vaccines: Strategies for cancer prevention | TBA |
| Talk 3 | Typhoid and Meningococcal Vaccines: Advances and implementation challenges | TBA |
| Talk 4 | Vaccines Against Arboviruses: Dengue, Zika, Chikungunya vaccine developments | TBA |
| Talk 5 | Updates on gastroenteritis (Rota, Noro) | TBA |
| Talk 6 | Updates on respiratory disease prevention | TBA |
| Talk 7 | RSV: New developments for pediatric and elderly populations | TBA |
| Talk 8 | Progress in combating high-burden diseases: Cholera | TBA |
| Talk 9 | Progress in combating high-burden diseases: Polio | TBA |
| Talk 10 | Progress in combating high-burden diseases: TB | TBA |
| Working Group Session | WHO guidelines on causality assessment of adverse events | TBA |
| Working Group Session | TBA | TBA |
| Panel | Immunization Information Systems: Data collection methods and tools, including electronic immunization registries | TBA |
| Panelist | TBA | TBA |
| Panelist | TBA | TBA |
Day 4
Vaccination Across the Life Span | Talk 1 | Maternal and Neonatal Immunization: Protecting mothers and infants through vaccination | TBA |
| Talk 2 | Vaccination schedule: Rationale behind timing and dosing intervals | TBA |
| Talk 3 | Immunization in the Elderly: Addressing immunosenescence and vaccine efficacy | TBA |
| Talk 4 | Life-Course Immunization: Promoting vaccination beyond childhood | TBA |
| Talk 5 | Balancing Individual Rights and Public Health Benefits | TBA |
| Talk 6 | Post-marketing effectiveness surveillance | TBA |
| Working Group Session | Roles of WHO SAGE, regional, and national advisory groups. Elements to be considered for informed-based decision making | TBA |
| Panel | Community Engagement and Mobilization: Building trust with communities | TBA |
| Panelist | TBA | TBA |
| Panelist | TBA | TBA |
| Panelist | TBA | TBA |
Day 5
Innovation, Collaboration, and Vaccine Access | Talk 1 | New Technologies and Tools: Digital innovations in immunization, advances in cold chain equipment and vaccine delivery | TBA |
| Talk 2 | Immunization in Public Health Emergencies and Humanitarian Settings: Strategies for Preparedness, Response, and Resilience | TBA |
| Talk 3 | International collaborations (WHO, UNICEF, GAVI, Gulf CDC, etc.) OR Regulatory harmonization and cross-border vaccine initiatives | TBA |
| Talk 4 | Reaching the Unreached: Strategies to Identify and Immunize Zero-Dose and Under-Vaccinated Populations | TBA |
| Talk 5 | AI, Bioinformatics, and Data Science in Vaccinology | TBA |
| Talk 6 | Enables regional vaccine independence: Manufacturing and Tech Transfer | TBA |
| Working Group Session | Interactive session – Quizzes: Fact or Fiction | TBA |
| Media Training | Crisis Communication: Responding to misinformation and rumors, Engaging with the media during adverse events | TBA |
Day 6 (Half Day)
Cross Discipline | Talk 1 | Vaccines at the One Health and Zoonotic Interface | TBA |
| Talk 2 | Countries’ Immunization Strategies: Lessons from different countries | TBA |
| Talk 3 | Countries’ Immunization Strategies: Lessons from different countries | TBA |
| Talk 4 | Closing remarks | TBA |
| Talk 5 | | |
| Talk 6 | | |
| Working Group Session / Panel | | |